This was the stock's second consecutive day of gains.

Although it sounds like an oxymoron, high-growth prospect dividend aristocrat stocks exist, although their industries may ...

Despite AbbVie’s underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a moderately ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Genmab reported strong Phase 3 trial results for epcoritamab in FL, secured FDA priority review, and raised its 2025 sales ...

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies ...

Allergan Aesthetics scored a big legal patent infringement win tied to its blockbuster wrinkle-treatment Botox. A federal ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...

The global cosmetic surgery market size was US$ 65.3 billion in 2021. The global cosmetic surgery market is expected to grow to US$ 165.0 billion by 2030 by registering a compound annual growth rate ...

August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epco ...

REGENXBIO to initiate pivotal phase IIb/III clinical trial of surabgene lomparvovec in diabetic retinopathy: Rockville, Maryland Friday, August 8, 2025, 15:00 Hrs [IST] REGENXBIO ...